The Business Development and Licensing (BD&L) Summit for Life Sciences is dedicated to valuable insights and actionable strategies on successfully managing alliances, licensing agreements and M&A deals.
The Business Development and Licensing (BD&L) Summit for Life Sciences covers topics such as:
- Implications of Today’s Reimbursement Environment on the Deal-Making Landscape
- Flexible partnership models spanning the breadth of drug discovery and development
- Patent litigation issues and trends and their impact on life science BD&L
- How to create a unique position of leverage during negotiations with multiple parties
- Key business goals and map out a clear strategy for potential M&As with respect to tax inversion, consolidation, divestitures, and narrowing strategic focus to maximize portfolio value
The Business Development and Licensing (BD&L) Summit for Life Sciences might be held in San Francisco, United States in Mar 2025.
